Bone drug reveals hidden strength: new imaging shows structure improvements beyond standard scans

This study looks at how teriparatide, a bone-building drug, affects the inner structure of bones in 100 men and women with osteoporosis over 24 months. Using a special 3D scanner, researchers measure changes in bone thickness and microarchitecture at the wrist and shin. The goal is to better understand how the drug strengthens bones beyond what standard bone density tests show, helping doctors and patients see the full picture of fracture risk reduction.